Publication:
Synthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors

dc.contributor.authorRatchanok Pingaewen_US
dc.contributor.authorPrasit Mandien_US
dc.contributor.authorVeda Prachayasittikulen_US
dc.contributor.authorSupaluk Prachayasittikulen_US
dc.contributor.authorSomsak Ruchirawaten_US
dc.contributor.authorVirapong Prachayasittikulen_US
dc.contributor.otherSouth Carolina Commission on Higher Educationen_US
dc.contributor.otherChulabhorn Research Instituteen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherSrinakharinwirot Universityen_US
dc.contributor.otherChulabhorn Graduate Instituteen_US
dc.date.accessioned2019-08-23T10:52:58Z
dc.date.available2019-08-23T10:52:58Z
dc.date.issued2018-01-01en_US
dc.description.abstract© 2017 Elsevier Masson SAS Thirty four of indoles bearing sulfonamides (11–44) were synthesized and evaluated for their anti-aromatase activities. Interestingly, all indole derivatives inhibited the aromatase with IC 50 range of 0.7–15.3 μM. Indoles (27–36) exerted higher aromatase inhibitory activity than that of ketoconazole. The phenoxy analogs 28 and 34 with methoxy group were shown to be the most potent compounds with sub-micromolar IC 50 values (i.e., 0.7 and 0.8 μM, respectively) without affecting to the normal cell line. Molecular docking demonstrated that the indoles 28, 30 and 34 could occupy the same binding site on the aromatase pocket and share several binding residues with those of the natural substrate (androstenedione), which suggested the competitive binding could be the mode of inhibition of the compounds. The most potent analog 28 could mimic H-bond interactions of the natural androstenedione with MET374 and ASP309 residues on the aromatase. QSAR model also revealed that the para-phenoxy indole (28) affords the higher value of electronegativity descriptor MATS6e as well as the higher inhibitory activity compared with that of the ortho-phenoxy compound (34). The study highlighted a series of promising indoles to be potentially developed as novel aromatase inhibitors for therapeutics.en_US
dc.identifier.citationEuropean Journal of Medicinal Chemistry. Vol.143, (2018), 1604-1615en_US
dc.identifier.doi10.1016/j.ejmech.2017.10.057en_US
dc.identifier.issn17683254en_US
dc.identifier.issn02235234en_US
dc.identifier.other2-s2.0-85033552512en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/45530
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85033552512&origin=inwarden_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleSynthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitorsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85033552512&origin=inwarden_US

Files

Collections